Steroids as Molecular Photonic Wires
J. Am. Chem. Soc., Vol. 121, No. 15, 1999 3629
acetate) showed the reaction to be complete. The slurry was diluted
with 100 mL of toluene and washed successively with cold 5% aqueous
sodium bicarbonate, cold 5% HCl, and cold 5% aqueous sodium
bicarbonate. The organic phase was dried (MgSO4) and concentrated
under vacuum to give a colorless oil. The material was purified by
using flash chromatography (9/1 hexane/ethyl acetate) to provide 3â-
((dimethylphenylsilyl)oxy)-17-(Z)-ethylidene-5R-androstane as a color-
less oil, which was recrystallized (2×) from acetonitrile to give a white
solid (2.39 g, 63.3% yield, mp 57-58 °C). GC analysis showed the
64.6, 54.9, 51.5, 48.8, 43.6, 41.9, 38.2, 38.0, 37.1, 36.1, 34.0, 31.4,
31.0, 23.8, 21.6, 12.2, 11.6.
3-(Ethylenedioxy)-6-methylene-5R-androstan-17â-ol (4.9 g, 14.1
mmol) was dissolved in 300 mL of acetone in an open flask equipped
with a mechanical stirrer. Jones reagent (18 mL) was added by pipet
while the ca. 20 °C reaction temperature was maintained. (The Jones
reagent was prepared by dissolving 67 g of chromium trioxide in 125
mL of water and slowly adding 58 mL of sulfuric acid with cooling.)
After the reaction slurry was stirred for 1 h, a small amount of
2-propanol was added to destroy any excess oxidant. The slurry was
worked up by removing most of the acetone under reduced pressure
and pouring the residue into 400 mL of water. The product was
extracted with ethyl acetate (3×), and the organic phase was washed
with 5% sodium bicarbonate and water. The product solution was dried
(MgSO4), and the solvent was removed under reduced pressure. The
crude 6-methylene-5R-androstane-3,17-dione was used in the next
reaction without further purification (GC assay 92.9%). An analytical
specimen was purified by recrystallization from cyclohexane (mp 186-
1
product to contain ca. 2.5% of the E isomer. H NMR: δ 7.36-7.61
(m, 5 H), 5.10 (q, 1 H), 3.59 (m, 1 H), 2.04-0.86 (m, 25 H), 0.85 (s,
3 H), 0.79 (s, 3 H), 0.38 (s, 6 H). 13C NMR: δ 150.5, 138.6, 133.5,
129.4, 127.7, 113.2, 72.3, 56.2, 54.4, 44.9, 44.4, 38.4, 37.2, 37.1, 35.5,
35.0, 31.9, 31.7, 31.4, 28.7, 24.4, 21.4, 16.9, 13.1, 12.3, -0.9, -1.0.
MS (CI): m/z 437 (13, M + H), 285 (100). HRMS (CI): m/z calculated
for C29H45OSi (M + H) 437.3240, found 437.3241.
3â-((Dimethylphenylsilyl)oxy)-17-(Z)-ethylidene-5-androstene (2).
17-(Z)-Ethylidene-3â-hydroxy-5-androstene was obtained from dehy-
droisoandrosterone (2.89 g, 10.0 mmol) in 92.7% yield (2.79 g) using
the general Wittig procedure and used for the next reaction without
further purification (mp 133-135 °C from cyclohexane, lit.10 mp 136-
1
187 °C, lit.15 mp 187-188 °C). H NMR: δ 4.82 (d, 1 H), 4.47 (d, 1
H), 2.55-0.95 (m, 20 H), 0.91 (s, 3 H), 0.87 (s, 3 H). 13C NMR: δ
220.4, 211.8, 147.2, 107.3, 54.1, 51.1, 50.8, 47.7, 40.5, 40.4, 38.0, 37.9,
37.7, 36.7, 35.7, 31.3, 21.7, 20.9, 13.8, 11.6.
1
137 °C). H NMR: δ 5.36 (m, 1 H), 5.13 (q, 1 H), 3.53 (m, 1 H),
2.42-1.04 (m, 23 H), 1.02 (s, 3 H), 0.90 (s, 3 H). 13C NMR: δ 150.3,
140.8, 121.6, 113.5, 71.7, 56.5, 50.1, 44.0, 42.3, 37.2, 36.9, 36.5, 31.7,
31.6, 31.42, 31.37, 24.5, 21.2, 19.4, 16.6, 13.1. MS (EI): m/z 300 (100,
M+), 285 (38), 267 (70);. HRMS (CI): m/z calculated for C21H33O (M
+ H) 301.2531, found 301.2530.
6-Methylene-5R-androstane-3,17-dione (3.4 g, 11.4 mmol) was
dissolved in 115 mL of THF. The solution was cooled to -78 °C, and
a 1.0 M solution of lithium tri-tert-butoxyaluminohydride (18.6 mL)
was added over 2.5 h with reaction monitoring by GC. The solution
was poured into 500 mL of 5% HCl, and the resulting slurry was
extracted with methylene chloride (3×). The combined methylene
chloride layers were washed with water and 5% sodium bicarbonate.
The solution was dried (MgSO4), concentrated under reduced pressure,
and purified with flash chromatography (1/1 hexane/ethyl acetate) to
give 2.4 g of 3â-hydroxy-6-methylene-5R-androstan-17-one (15; mp
135-136 °C, toluene) and 0.5 g of recovered starting material (83%
yield based on recovered starting material). 1H NMR: δ 4.76 (d, 1 H),
4.51 (d, 1 H), 3.64 (m, 1 H), 2.49-0.88 (m, 21 H), 0.85 (s, 3 H), 0.71
(s, 3 H). 13C NMR: δ 220.9, 148.5, 106.6, 71.2, 54.7, 51.3, 49.3, 47.9,
40.7, 37.8, 36.9, 36.5, 35.8, 33.6, 31.4, 31.2, 21.7, 20.7, 13.8, 12.4.
MS (EI): m/z 302 (100, M+), 284 (41), 269 (42), 91 (72). HRMS
(CI): m/z calculated for C20H31O2 (M + H) 303.2324, found 303.2323.
17-(Z)-Ethylidene-3â-hydroxy-5-androstene (1.08 g, 3.61 mmol) was
treated with chlorodimethylphenylsilane (0.61 mL, 3.61 mmol) ac-
cording to the general DPSO procedure. The material was purified by
using flash chromatography (20/1 hexane/ethyl acetate) to provide the
product as a white solid, which was recrystallized (2×) from acetonitrile
to give white crystals (0.953 g, 60.7% yield). GC analysis showed the
product to contain ca. 2.0% of the E isomer (mp 73-74 °C). 1H
NMR: δ 7.36-7.60 (m, 5 H), 5.26 (m, 1 H), 5.14 (q, 1 H), 3.56 (m,
1 H), 2.42-1.02 (m, 22 H), 1.00 (s, 3 H), 0.88 (s, 3 H) 0.390 (s, 3 H),
0.385 (s, 3 H). 13C NMR: δ 150.3, 141.3, 138.5, 133.4, 129.5, 127.7,
121.2, 113.4, 72.7, 56.5, 50.1, 44.0, 42.5, 37.2, 37.0, 36.6, 31.8, 31.7,
31.42, 31.37, 24.5, 21.2, 19.3, 16.6, 13.1, -1.0, -1.1. MS (EI): m/z
434 (16, M+), 356 (48), 135 (100). HRMS (CI): m/z calculated for
C29H43OSi (M + H) 435.3083, found 435.3083.
3â-Hydroxy-6-methylene-5R-androstan-17-one (1.0 g, 3.3 mmol)
was treated with potassium tert-butoxide (16.6 mL, 1.0 M solution in
THF) and ethyltriphenylphosphonium bromide (6.1 g, 16.6 mmol)
according to the general Wittig procedure. The 17-(Z)-ethylidene-3â-
hydroxy-6-methylene-5R-androstane product was obtained in 75% yield
(0.78 g, mp 155-157 °C, cyclohexane) and used for the next reaction
3â-((Dimethylphenylsilyl)oxy)-17-(Z)-ethylidene-6-methylene-5r-
androstane (3a). 17â-Hydroxy-5R-androstane-3,6-dione was prepared
by following the reported literature procedure in 65% overall yield from
testosterone acetate.11 1H NMR: δ 3.69 (t, 1 H), 2.61-1.18 (m, 21 H),
0.97 (s, 3 H), 0.78 (s, 3 H).
1
without further purification. H NMR: δ 5.12 (q, 1 H), 4.73 (d, J )
17â-Hydroxy-5R-androstane-3,6-dione was treated on the basis of
the procedure of Rosenkranz et al.12 This steroid (11.53 g, 37.9 mmol)
was placed in a dry flask with 138 mL of 2-methyl-2-ethyl-1,3-
dioxolane and 0.46 g of p-TSA. The mixture was quickly heated to
reflux and held at reflux for 5 min. The resulting reaction solution was
cooled in an ice bath, during which time crystals appeared. Isolation
of the filter cake gave 5.59 g of 3-(ethylenedioxy)-17â-hydroxy-5R-
androstan-6-one (42.4% yield, GC assay 97.6%; mp 189-190 °C from
1.46, 1 H), 4.47 (d, J ) 1.46, 1 H), 3.65 (m, 1 H), 2.36-0.89 (m, 24
H), 0.86 (s, 3 H), 0.70 (s, 3 H). 13C NMR: δ 150.1, 149.4, 113.4,
106.0, 71.5, 56.1, 54.7, 49.3, 44.4, 41.8, 37.8, 37.1, 37.0, 36.5, 33.7,
31.4, 31.3, 24.3, 21.7, 16.9, 13.1, 12.4. MS (EI): m/z 314 (100, M+),
299 (68), 281 (24). HRMS (CI): m/z calculated for C22H35O (M + H)
315.2688, found 315.2688.
17-(Z)-Ethylidene-3â-hydroxy-6-methylene-5R-androstane (0.76 g,
2.42 mmol) was treated with chlorodimethylphenylsilane (0.41 mL,
2.4 mmol) according to the general DPSO procedure. The material was
purified by using flash chromatography (9/1 hexane/ethyl acetate) to
provide 3a as a colorless oil. After it was held under vacuum overnight,
the material formed a fused solid, which was crystallized from
acetonitrile to give white needles (0.70 g, 80% yield; mp 82-83 °C).
GC analysis showed the product to contain ca. 1.0% of the E isomer.
The material was recrystallized again prior to use (0.4% E isomer). 1H
NMR: δ 7.63-7.35 (m, 5 H), 5.12 (q, 1 H), 4.70 (m, 1 H), 4.44 (m,
1 H), 3.62 (m, 1 H), 2.33-1.16 (m, 23 H), 0.85 (s, 3 H), 0.68 (s, 3 H)
0.40 (s, 6 H). 13C NMR: δ 150.2, 149.6, 138.5, 133.5, 129.5, 127.8,
113.3, 105.9, 72.5, 56.1, 54.7, 49.4, 44.4, 41.8, 37.8, 37.1, 37.0, 36.6,
34.0, 31.5, 31.4, 24.3, 21.6, 16.9, 13.1, 12.4, -0.9, -1.0. MS (EI):
m/z 448 (97, M+), 433 (39), 281 (44), 137 (100). HRMS (CI): m/z
calculated for C30H45OSi (M + H) 449.3240, found 449.3240.
1
cyclohexane/ethyl acetate). H NMR: δ 3.87-3.99 (m, 4 H), 3.69 (t,
1 H, C17RH), 2.55-1.13 (m, 21 H), 0.78 (s, 3 H, C19-CH3), 0.75 (s,
3 H, C18-CH3). 13C NMR: δ 211.1. 109.1, 81.6, 64.4, 64.3, 56.2,
53.8, 51.5, 46.2, 43.5, 41.0, 38.0, 36.4, 35.8, 30.9, 30.5, 29.9, 23.3,
21.2, 12.6, 11.2. MS (EI): m/z 348 (91, M+), 319 (47), 99 (100). HRMS
(CI) m/z calculated for C21H33O4 (M + H) 349.2379, found 349.2378.
3-(Ethylenedioxy)-17â-hydroxy-5R-androstan-6-one (5.59 g, 16.1
mmol) was treated with potassium tert-butoxide (48.2 mL, 1.0 M
solution in THF) and methyltriphenylphosphonium bromide (17.2 g,
48.15 mmol) according to the general Wittig procedure. The mixture
was stirred overnight, and the isolated product was purified by flash
chromatography (1/1 hexane/ethyl acetate). The 3-(ethylenedioxy)-6-
methylene-5R-androstan-17â-ol product13 was obtained in 93% yield
1
(5.2 g) and used for the next reaction without further purification. H
NMR: δ 4.7 (d, J ) 1.47 Hz, 1 H), 4.4 (d, J ) 1.47 Hz, 1 H), 3.96-
3.93 (m, 4 H), 3.54 (t, 1 H), 2.24-1.00 (m, 21 H), 0.72 (s, 3 H, C19-
CH3), 0.70 (s, 3 H, C18-CH3). 13C NMR: δ 149.9, 110.1, 105.2, 82.3,
3r-((Dimethylphenylsilyl)oxy)-17-(Z)-ethylidene-6-methylene-5r-
androstane (3b). 3R-Hydroxy-5R-androstane-6,17-dione was prepared